Subscribe to Newsletter

February 2024 Issue of The Medicine Maker

COVID-19 continues to exert its effect on the world; we look at what lessons have been learned from the crisis and how Europe is planning manufacturing capacity for future emergencies. Sustainability is also a key topic for this issue with Vetter’s Henryk Badack giving his thoughts on how companies can be more energy efficient, and TekniPlex’s Michiel van den Berg discussing the packaging and recyclability. Also covered: the impact of gene therapies on diseases of the eye, enteric-coated suforaphanes, the labs of pharma’s future, and much more.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Forgot your password?
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

 Manufacture Advanced Medicine

What’s Happening with CAR T Therapies?

| Stephanie Vine | 3 min read

A look at the FDA’s safety investigation into CAR T therapeutics.

Discovery & Development Drug Discovery

Pharma’s Portal to the Lab of the Future

| Becky Upton | 4 min read

Labs of the future will use VR, AR, AI and more. But we must overcome the barriers of implementation, including cultural resistance.
Business & Regulation Business Practice

A Terrifying Awakening

| Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?
Manufacture Bioprocessing - Upstream & Downstream

Propelling the Promise of mRNA

| Rob Coker | 4 min read

With mRNA technology scooping the 2023 Nobel Prize for Medicine, demand is growing. Can CDMOs keep up?
Discovery & Development Formulation

The Sulforaphane Promise

| Helen Kuhlman | 4 min read

Sulforaphane has therapeutic potential in numerous areas but formulation is key. Can enteric coatings help find the way forward?
Discovery & Development Drug Delivery

At First Sight

| Jamie Irvine | 13 min read

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space
Business & Regulation Business Practice

Being Mindful of the World

| Stephanie Vine | 10 min read

From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable.
Manufacture Packaging

The Age of Upcycling Is Here

| Michiel van den Berg | 6 min read

We are witnessing a new era in primary packaging for pharmaceuticals.

Discovery & Development Drug Discovery

Making Miracles

| 6 min read

After serving as Head of Research Development at Trinity College Dublin, Fiona Killard-Lynch became Director of Research and Innovation at NIBRT

Other issues of 2024